Table VI: Aspects that are Included in a Number of Existing Guidelings
| Guideline | Use of FCA | Use of other Adjuvants | Dif. Routes | Preferred Routes | Immun. Protocols | Preferred Interval Prime-Boost | Observ. after Injection | Background Inform. and Ref. |
| ANZCCART | + | + | + | + | + | + | ||
| ATBW | + | + | + | s.c. | + | > 4 weeks | ||
| BVET | + | + | + | s.c. | + | > 4 weeks | + | |
| CCAC | + | + | + | |||||
| HO | + | + | s.c. | + | ||||
| NIH | + | + | ||||||
| TVT | + | + | + | +? | + | > 4 weeks | + | + |
| VPHI | + | + | + | s.c. | + | > 4 weeks | + | + |
| Danish guidelinesa | + | + | + | s.c. or deep i.m. | + | + | + |
s.c. = subcutaneous, i.m. = intramuscular.
ANZCCART = Australian and New Zealand Council for the Care of Animals in Research and Teaching (Australia/New Zealand; 50), ATBW = rbeitsgemeinschaft der Tierschutzbeauftragten in Baden-Württemberg (Germany; 51), BVET = Bundesamt für Veterinärwesen (Switzerland; 15), CCAC = Canadian Council on Animal Care (Canada; 30), HO = Home Office (UK; 47), NIH = National Institutes of Health (USA; 46), TVT = Tierärzliche Vereinigung für Tierschutz (Germany; 22), VPHI = Veterinary Public Health Inspectorate (The Netherlands; 31).
aData from reference 16.